换一批
换一批Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
第一作者：
H Joachim,Deeg
第一单位：
Fred Hutchinson Cancer Research Center and University of Washington School of Medicine, Seattle, Washington 98109-1024, USA. jdeeg@fhcrc.org
作者：
主题词
急性病(Acute Disease);青少年(Adolescent);成年人(Adult);老年人(Aged);抗淋巴细胞血清(Antilymphocyte Serum);白消安(Busulfan);死亡原因(Cause of Death);儿童(Child);慢性病(Chronic Disease);队列研究(Cohort Studies);共病现象(Comorbidity);环磷酰胺(Cyclophosphamide);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);药物疗法, 联合(Drug Therapy, Combination);爱泼斯坦巴尔病毒感染(Epstein-Barr Virus Infections);女(雌)性(Female);移植物排斥(Graft Rejection);移植物抗宿主病(Graft vs Host Disease);疱疹病毒4型, 人(Herpesvirus 4, Human);人类(Humans);发病率(Incidence);白血病, 髓样(Leukemia, Myeloid);男(雄)性(Male);中年人(Middle Aged);骨髓增生异常综合征(Myelodysplastic Syndromes);外周血干细胞移植(Peripheral Blood Stem Cell Transplantation);复发(Recurrence);T淋巴细胞(T-Lymphocytes);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome);病毒激活(Virus Activation)
DOI
10.1016/j.bbmt.2005.12.036
PMID
16635793
发布时间
2021-10-20
- 浏览8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
